Optiscan has been featured on Stockhead’s “What the Facts” video series, showcasing how the company is transforming pathology through real-time digital imaging.

In the interview, CEO Dr. Camile Farah discusses how Optiscan is tackling long-standing inefficiencies in pathology by replacing traditional, slide-based workflows with immediate, high-resolution imaging at the point of tissue collection. Optiscan’s next-generation technology digitises the entire pathology workflow from start to finish—enhancing speed, accuracy, and accessibility in clinical settings.

“We’re basically transforming the whole process, and we’re making it digital from the beginning right to the end, from the second that sample hits our device to the second the report is generated,” said Dr. Farah.

Watch the full video interview here.